Viewing Study NCT02836704


Ignite Creation Date: 2025-12-24 @ 9:15 PM
Ignite Modification Date: 2026-01-02 @ 6:27 AM
Study NCT ID: NCT02836704
Status: COMPLETED
Last Update Posted: 2022-04-25
First Post: 2016-07-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module